NHS bosses approve drug that fights arthritis linked to psoriasis that affects thousands of young people

Sly Saint · Sep 10, 2023

Thousands living with forms of arthritis that affect younger people will soon benefit from a new drug which has been approved by NHS health chiefs.

Pivotal studies have found that the drug, bimekizumab, can dramatically reduce joint pain and swelling for those with a type of arthritis linked to the skin condition psoriasis, known as psoriatic arthritis.

Separate research has found it can also improve the debilitating symptoms of axial spondyloarthritis, known as axial SpA, another type of arthritis that causes pain and stiffness in the lower back when the joints become swollen.

Bimekizumab is particularly effective for those who are resistant to other treatments, offering a crucial solution to patients who have run out of options.
Click to expand...

NHS bosses approve drug that fights arthritis linked to psoriasis that affects thousands of young people and is suffered by Kim Kardashian | Daily Mail Online

Log in or Sign up

NHS bosses approve drug that fights arthritis linked to psoriasis that affects thousands of young people

Sly Saint Senior Member (Voting Rights)

Share This Page

Log in or Sign up

NHS bosses approve drug that fights arthritis linked to psoriasis that affects thousands of young people

Sly Saint Senior Member (Voting Rights)

Share This Page

Useful Searches